🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
RATIONALE: ABT-510 may stop the growth of melanoma by blocking blood flow t...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00602199
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
A retrospective observational study to evaluate immunohistochemical express...
Status
Unknown
Location
Sohag University hospitals
Start Date
2021-01-01
Trial ID
NCT05794737
Treatments Being Tested
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be a...
Status
Terminated
Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Start Date
2007-02
Trial ID
NCT00667901
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
RATIONALE: Studying samples of blood and/or tissue in the laboratory from p...
Status
Completed
Location
Addenbrooke's Hospital
Start Date
2007-07
Trial ID
NCT00900536
RATIONALE: Studying proteins in head and neck cancer cells in the laborator...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2005-05
Trial ID
NCT00896948
RATIONALE: Bafetinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
City of Hope Medical Center
Start Date
2010-12
Trial ID
NCT01234740
The main goal of this study is to employ a novel proteomic approach to iden...
Status
Unknown
Location
Hillel Yaffe Medical Center
Start Date
2016-04
Trial ID
NCT02719041
Treatments Being Tested